Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | LIMK1 | P53667 | 3/20 | 0.40 |
| ▸ | PARP1 | P09874 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.37 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.37 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TNKS | O95271 | 1/20 | 0.35 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.35 |
| ▸ | KRAS | P01116 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18232837 | 0.81 | KDM4E (0.41) | GPR3RAB9AKMT2ALIMK1NPC1 | |
| SCHEMBL15582025 | 0.80 | LIMK1 (0.43) | GPR3RAB9AMEN1KMT2ALIMK1 | |
| SCHEMBL15581954 | 0.80 | LIMK1 (0.43) | GPR3RAB9AMEN1KMT2ALIMK1 | |
| SCHEMBL15582067 | 0.80 | LIMK1 (0.43) | GPR3RAB9AMEN1KMT2ALIMK1 | |
| SCHEMBL25462902 | 0.80 | MEN1 (0.52) | MEN1KMT2AALDH1A1 | |
| SCHEMBL15582121 | 0.78 | PARP1 (0.41) | RAB9AMEN1KMT2ALIMK1PARP1 | |
| SCHEMBL28900130 | 0.78 | MIF (0.51) | GPR3RAB9AMEN1KMT2ALIMK1 | |
| SCHEMBL24057813 | 0.78 | CYP1A2 (0.35) | RAB9ALIMK1NPC1ALDH1A1 | |
| SCHEMBL25463040 | 0.78 | LMNA (0.38) | RAB9AMEN1KMT2ANPC1ACHE | |
| SCHEMBL18232854 | 0.78 | KDM4E (0.38) | GPR3RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118255815-A | Organic metal compound, preparation method thereof and light-emitting device | 吉林奥来德光电材料股份有限公司 | 2024-06-28 | — | — | CN | disclosed |
| US-20160336517-A1 | Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-11-17 | — | — | US | disclosed |
| US-20160336517-A1 | Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-11-17 | — | — | US | disclosed |
| US-7445857-B2 | Organometallic complex and organic electroluminescent devices utilizing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2008-11-04 | — | — | US | disclosed |
| US-20070237981-A1 | Organometallic complex and organic electroluminescent devices utilizing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160336517-A1 | Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | NR2E3, LEF1, LAGE3 | GPR3 2633/4885RAB9A 3719/4885MEN1 3483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.